Enhanced differentiation of functional human T cells in NSGW41 mice with tissue-specific expression of human interleukin-7

  • Emilie Coppin
  • Bala Sai Sundarasetty
  • Susann Rahmig
  • Jonas Blume
  • Nikita A. Verheyden
  • Franz Bahlmann
  • Sarina Ravens
  • Undine Schubert
  • Janine Schmid
  • Stefan Ludwig
  • Katharina Geissler
  • Orlando Guntinas-Lichius
  • Constantin von Kaisenberg
  • Tanja Groten
  • Alexander Platz
  • Ronald Naumann
  • Barbara Ludwig
  • Immo Prinz
  • Claudia Waskow
  • Andreas Krueger

Abstract

Humanized mouse models have become increasingly valuable tools to study human hematopoiesis and infectious diseases. However, human T-cell differentiation remains inefficient. We generated mice expressing human interleukin-7 (IL-7), a critical growth and survival factor for T cells, under the control of murine IL-7 regulatory elements. After transfer of human cord blood-derived hematopoietic stem and progenitor cells, transgenic mice on the NSGW41 background, termed NSGW41hIL7, showed elevated and prolonged human cellularity in the thymus while maintaining physiological ratios of thymocyte subsets. As a consequence, numbers of functional human T cells in the periphery were increased without evidence for pathological lymphoproliferation or aberrant expansion of effector or memory-like T cells. We conclude that the novel NSGW41hIL7 strain represents an optimized mouse model for humanization to better understand human T-cell differentiation in vivo and to generate a human immune system with a better approximation of human lymphocyte ratios.

Bibliographical data

Original languageEnglish
ISSN0887-6924
DOIs
Publication statusPublished - 12.2021
Externally publishedYes

Comment Deanary

Funding Information:
Funding The work was supported by grants from the German Research Foundation (DFG, SFB738-A7, and SFB902-B15) (to AK) and FOR2033-A03, TRR127-A5, WA2837/6-1, WA2837/7-1, the SAW program on collaborative excellence of the Leibniz Association (K243/2019) and through the project EDISCIDPROG funded by the EU ERA-Net for Research Programmes on Rare Diseases, E-Rare (to CW). Open Access funding enabled and organized by Projekt DEAL.

Publisher Copyright:
© 2021, The Author(s).

Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.